Clinical trial
A Phase 2 Study to Compare Two Presentations of CagriSema in Participants With Type 2 Diabetes
NCT07357740 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study to Compare Two Presentations of CagriSema in Participants With Type 2 Diabetes
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- August 27, 2026
- Completion date
- October 13, 2027
- Enrollment
- 0 (actual)
- Sites
- 61
Conditions
As the registry lists them; a condition with its own page is linked.